Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Greff
Andrew Julius Greff, Stouffville CA
| Patent application number | Description | Published |
|---|---|---|
| 20090132702 | Generic Method for Resource Monitoring Configuration in Provisioning Systems - A generic mechanism and model are provided to capture and store configuration profiles for resource monitors such that monitors can be flexibly deployed, configured, modified, and removed using appropriate sets of parameters and values. As an integral part of resource provisioning, this generic mechanism will require only a generic set of workflows and a generic data model to provision monitors. The provisioning system of the present invention captures and stores response parameters and values from monitors created during initial deployment such that these parameters can be used for later modification and removal of these monitors. | 05-21-2009 |
Andrew K. Greff, Austin, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20090132678 | SYSTEM AND METHOD FOR REMOTELY ACTIVATING A SERVICE AND SERVICE MANAGEMENT SYSTEM INCORPORATING THE SAME - A service management system and a method of remotely activating a service. In one embodiment, the service management system includes: (1) a service description repository configured to contain service descriptions that define services in terms of a set of end points that assume roles based on at least one of the capabilities and attributes thereof and (2) a service management engine coupled to the service description repository and configured to employ at least one relationship contained in one of the service descriptions in the service description repository to pre-qualify ones of the end points associated with one of the services and activate the one of the services with respect to a subscriber. | 05-21-2009 |
Daniel Greff, Mere FR
| Patent application number | Description | Published |
|---|---|---|
| 20110066087 | METHOD AND APPARATUS FOR REDUCING EXCESS ADIPOSE TISSUE - The adipose areas of the body are simultaneously subjected to lipolysis, through the action of an apparatus that generates low-frequency electromagnetic waves, to extraction, out of the adipose cells, of the fatty acids released by the lipolysis, and to drainage of the fatty acids to the vascular and lymphatic system, through the action of a pressotherapy apparatus. | 03-17-2011 |
Daniel Thomas Greff, Irving, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20090076865 | METHODS TO PROVISION, AUDIT AND REMEDIATE BUSINESS AND IT ROLES OF A USER - A business role for a user is selected based on a job title of the user. IT roles are identified based on the selected business role. Provisioned IT roles of the user are compared to the identified IT roles. Differences between the identified and provisioned IT roles are remedied. The differences may be remedied by changing the business role definition. | 03-19-2009 |
Raphael Greff, Loos FR
| Patent application number | Description | Published |
|---|---|---|
| 20120020443 | METHOD FOR PROCESSING A SIGNAL, IN PARTICULAR A DIGITAL AUDIO SIGNAL - The invention relates to a method for processing a signal, in particular a digital audio signal, suitable for being implemented by a digital signal processor (DSP) having libraries for calculating Fourier transforms from the complex number space to the complex number space, for digitally processing P input signals, P being an integer at least equal to 2, more particularly for filtering said P input signals by the convolution of sampled fast Fourier transforms (FFT), thus obtaining Q output signals, Q being an integer at least equal to 2. According to the invention, the method includes at least the following steps: grouping said P input signals by twos, one representing the real portion and the other the imaginary portion of a complex number, thus defining one or more input vectors, filtering said input vector or vectors, passing through the Fourier space, thus generating one or more output vectors, which are complex numbers, the real portion and the imaginary portion of said vector or each one of said output vectors respectively representing one of said Q output signals. | 01-26-2012 |
Richard Greff, St. Pete Beach, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20110014290 | SYSTEM AND METHOD FOR FACILITATING HEMOSTASIS WITH AN ABSORBABLE SPONGE - The present invention provides for a method and apparatus to provide hemostasis at a blood vessel puncture site, having a hemostasis material and a clot formation accelerator, wherein said clot formation accelerator is substantially dispersed throughout said hemostasis material. | 01-20-2011 |
Richard J. Greff, Pete Beach, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20110172768 | KNEE JOINT PROSTHESIS AND HYALURONATE COMPOSITIONS FOR TREATMENT OF OSTEOARTHRITIS - A medical device and methods to relieve joint pain and adapted for knee joint repair, replacement and augmentation. The invention discloses joint lubricant, particularly hyaluronate compositions and methods for treatment of osteoarthritis. | 07-14-2011 |
Richard J. Greff, St. Pete Beach, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20110264073 | DEVICE AND METHOD FOR CONTROLLING INJECTION OF LIQUID EMBOLIC COMPOSITION - A liquid embolic delivery system is provided for trapping an injected liquid embolic composition to prevent the liquid embolic from solidifying or otherwise passing outside of an embolization area. The delivery system includes a catheter for delivery of a liquid embolic composition and a containment member positioned at a distal end of the catheter which is shaped to trap the liquid embolic composition delivered through the lumen of the catheter. The containment member is formed as a brush, nest, sponge, swab, flexible sack, or other shape into and around which the liquid embolic composition is injected. The liquid embolic composition is trapped or meshes with the containment member during solidification containing the liquid embolic and preventing the embolic composition from passing into the blood stream. | 10-27-2011 |
Zoltán Greff, Budapest HU
| Patent application number | Description | Published |
|---|---|---|
| 20090018149 | 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and methods for medical intervention against mycobacterial infections - Described are 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and pharmaceutically acceptable salts thereof, the use of these derivatives for the prophylaxis and/or treatment of mycobacteria-induced infections and opportunistic infections, as well as compositions containing at least one 4,5,6,7-tetrahydrobenzo[b]thiophene derivative and/or pharmaceutically acceptable salts thereof. Furthermore, the present application refers to the use of mycobacterial protein serine/threonine kinases for developing methods for detection and determination of these kinases for recognising and monitoring diseases and for controlling therapy of diseases. | 01-15-2009 |
| 20090233913 | OPTICAL ISOMERS OF DIHYDRO-2,3-BENZODIAZEPINES AND THEIR STEREOSELECTIVE SYNTHESIS - The present invention relates to dihydro-2,3-benzodiazepine compounds of high enantiomeric purity according to the general formula (I), which contain an asymmetric centre at the position 4 of the dihydro-2,3-benzodiazepine compound, and the preparation thereof and the used intermediates as well. These compounds have anti-convulsiveA muscle relaxant and neuroprotective effect due their non-competitive AMPA antagonistic properties. | 09-17-2009 |
| 20090298842 | Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor - Described herein is the discovery that certain mycobacterial serine/threonine protein kinases, particularly protein kinase G (PknG), are effective therapeutic targets for the treatment of mycobacterial infections. Furthermore, the present application refers to the use of mycobacterial serine/threonine protein kinases for developing methods for detection and determination of these kinases for recognizing and monitoring diseases and for controlling therapy of diseases. Additionally disclosed are novel 4,5,6,7-tetrahydrobenzo[b]thiophene compounds, benzo(g)quinoxaline compounds, and pharmaceutically acceptable salts thereof, and methods of using such compounds and salts thereof for the prophylaxis and/or treatment of virally and/or bacterially induced infections, particularly mycobacteria-induced infections, including opportunistic infections, as well as pharmaceutical compositions containing at least one 4,5,6,7-tetrahydrobenzo[b]thiophene compound and/or benzo(g)quinoxaline compound and/or pharmaceutically acceptable salts thereof in a pharmaceutically acceptable carrier. | 12-03-2009 |